Combined Targeting of mTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex

por Ji, Shuang, Lin, Wei, Wang, Li, Ni, Zhaofei, Jin, Fuquan, Zha, Xiaojun, Fei, Guanghe
Publicado 2017

Hyperactivated mTORC1 downregulation of FOXO3a/PDGFRα/AKT cascade restrains tuberous sclerosis complex-associated tumor development

por Wang, Li, Ni, Zhaofei, Liu, Yujie, Ji, Shuang, Jin, Fuquan, Jiang, Keguo, Ma, Junfang, Ren, Cuiping, Zhang, Hongbing, Hu, Zhongdong, Zha, Xiaojun
Publicado 2017

mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency

por Li, Hongwu, Jin, Fuquan, Jiang, Keguo, Ji, Shuang, Wang, Li, Ni, Zhaofei, Chen, Xianguo, Hu, Zhongdong, Zhang, Hongbing, Liu, Yehai, Qin, Yide, Zha, Xiaojun
Publicado 2016

AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development

por Wan, Xiaofeng, Zhou, Meng, Huang, Fuqiang, Zhao, Na, Chen, Xu, Wu, Yuncui, Zhu, Wanhui, Ni, Zhaofei, Jin, Fuquan, Wang, Yani, Hu, Zhongdong, Chen, Xianguo, Ren, Min, Zhang, Hongbing, Zha, Xiaojun
Publicado 2021